Inhibrx Biosciences Growth Metrics (2023-2025) | INBX

Growth Metrics Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 26.04M-4.45M0.07M-0.21M
EBITDA Margin (QoQ) 21.89M3.31M0.63M0.21M5.15M-0.07M0.02M
EBIT Margin Growth (1y) 26.04M-4.45M0.07M-0.21M
EBIT Margin (QoQ) 21.89M3.31M0.63M0.21M5.15M-0.07M0.02M
EBT Margin Growth (1y) 25.31M-4.22M0.06M3.56M
EBT Margin (QoQ) 24.42M3.79M0.66M-3.56M4.95M-0.07M0.02M
Enterprise Value Growth (1y) 125.31%153.55%1,002.64%
Enterprise Value (QoQ) 181.41%131.66%-119.91%242.63%1,576.26%
FCF Margin Growth (1y) -4.00M0.05M-0.01M
FCF Margin (QoQ) 4.24M0.45M0.03M4.51M-0.04M0.01M
Interest Coverage Ratio Growth (1y) -418.64%-75.70%70.95%
Interest Coverage Ratio (QoQ) 2.82%-90.92%15.43%-230.52%45.34%-21.90%
Net Margin Growth (1y) 25.31M-4.22M0.06M3.56M
Net Margin (QoQ) 24.42M3.79M0.66M-3.56M4.95M-0.07M0.02M
Operating Margin Growth (1y) 26.04M-4.45M0.07M-0.21M
Operating Margin (QoQ) 21.89M3.31M0.63M0.21M5.15M-0.07M0.02M
Return on Assets Growth (1y) -763.00
Return on Assets (QoQ) 153.00-23.00-886.00-8.00
Return on Capital Employed Growth (1y) 91.00
Return on Capital Employed (QoQ) -18.0027.0090.00-8.00
Return on Equity Growth (1y) -0.00M
Return on Equity (QoQ) 255.00430.00-0.00M-93.00
Return on Sales Growth (1y) -0.01M0.02M
Return on Sales (QoQ) -0.02M0.00M0.01M264.00